Received Apr 14, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
patient received one dose of Shingrix in 2021; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a elderly male patient who did not receive Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (received 1st dose in 2021). On an unknown date, the patient did not receive the 2nd dose of Shingrix. The patient experienced incomplete course of vaccination (Verbatim: patient received one dose of Shingrix in 2021). The outcome of the incomplete course of vaccination was not applicable. Additional Information: GSK receipt date: 07-APR-2026 The pharmacist reported that a patient received one dose of Shingrix in 2021. This was the patient first and only dose. Lot number, expiration date, and administration date were asked for but not provided, as the pharmacist stated they work with individuals in correctional facilities and did not have all information available. No further details were provided. The batch number was not provided and a request for this information has been made.